Once clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic ... hepatic sarcoidosis, ...

of 135 Italian PBC patients, but in none of 157 pathological controls including type 1 AIH (n = 91), PSC (n=34) and SLE (n=32). In our experience anti-Sp140 are 100% PBC-specific and may coexist ...

LKM = Anti-liver-kidney-microsomal antibody; NPC = Nuclear pore complex; pANCA = Perinuclear antineutrophil cytoplasmic antibody; PBC = Primary biliary cirrhosis; PSC = Primary sclerosing ...

In the absence of these autoantibodies, further serological testing may include detection of anti-SLA/LP, as well as autoantibodies that may help rule out diseases such as PBC, PSC or celiac disease.

Autoimmune liver diseases (ALDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today results ...

Primary biliary cholangitis (PBC) is a rare liver disease. It blocks and destroys bile ducts in the liver. Doctors used to call it “primary biliary cirrhosis.” “Biliary” means bile.

The most common types of CLDs are primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). CLDs are classified into intrahepatic and extrahepatic types based on their etiology.

Fibroinflammatory cholangiopathies, such as PSC and primary biliary cholangitis (PBC), are characterized by ... "The new findings reinforce the anti-fibrotic activity of Aramchol previously ...

Primary biliary cholangitis (PBC) is a rare autoimmune disease affecting the bile ducts in the liver. When bile ducts become damaged, bile can build up in the liver, leading to inflammation and ...

Galmed_Pharmaceuticals_Logo Fibroinflammatory cholangiopathies, such as PSC and primary biliary cholangitis (PBC), are characterized by cholestatic injury, inflammation and fibrosis-induced ...